Index of reports
> Cases with Febrile Neutropenia (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Navelbine (Vinorelbine) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Navelbine side effects in 64 year old female
Reported by a individual with unspecified qualification from Italy on 2012-07-24
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Navelbine
Dosage: 37.5 mg, unk, iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-15
Cisplatin
Dosage: 40 mg unk, iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-09
Other drugs received by patient: Glutathione Sodiuim; Desamethasone Fost
Possible Navelbine side effects in 64 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-03
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Navelbine
Dosage: 37.5 mg unk iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-15
Cisplatin
Dosage: 40 mg unk iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-09
Other drugs received by patient: Glutathione Sodium; Desametasone Fosf
Possible Navelbine side effects in 64 year old female
Reported by a physician from Italy on 2012-06-27
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 50mg/100ml (cyclical)
Indication: Lung Adenocarcinoma
Start date: 2011-06-08
End date: 2011-06-09
Navelbine
Dosage: 37.5 (10 mg/ml,cyclical)
Indication: Lung Adenocarcinoma
Start date: 2011-06-08
End date: 2011-06-15
Other drugs received by patient: Desametasone Fosfato Hospira; Glutatione Sodico
Possible Navelbine side effects in 14 year old female
Reported by a physician from United States on 2012-06-07
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temsirolimus
Dosage: days 1, 8 and 15 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Cyclophosphamide
Dosage: day 1 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Navelbine
Dosage: days 1 and 8, over 6-10 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06
Patient: female, weighing 12.7 kg (27.9 pounds)
Reactions: Mucosal Inflammation, Fungaemia, Febrile Neutropenia, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ifosfamide
Dosage: dadys 1 and 2
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Mesna
Start date: 2011-09-21
Mesna
Mesna
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Cyclophosphamide
Dosage: 11 mg
Administration route: Oral
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Doxorubicin HCL
Dosage: days 1 and 2
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Dactinomycin
Dosage: day 1 of cycle
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Vincristine
Dosage: days 1, 8 and 15 of cycle
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Bevacizumab
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Navelbine
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Other drugs received by patient: Ondansetron; Ondansetron; Levomepromazine; Docusate; Gentamycin Sulfate; Piperacillin and Tazobactam; Ondansetron; Neupogen; Levomepromazine; Docusate; Fluconazole; Docusate; Dihydrocodeine Bitartrate INJ; Ondansetron; Movicol / 01625101 /; Movicol / 01625101 /; Neupogen; Acetaminophen; Morphine; Movicol / 01625101 /; Cotrim
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-05-29
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Exemestane
Dosage: 25 mg, qd
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-10-19
End date: 2010-11-30
Placebo
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-10-19
End date: 2010-11-30
Fluorouracil
Dosage: 750 mg, 2/month
Indication: Breast Cancer
Start date: 2010-11-30
End date: 2010-12-07
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-10-19
End date: 2010-11-30
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-10-19
End date: 2010-11-30
Navelbine
Dosage: 35 mg, 4/month
Indication: Breast Cancer
Start date: 2010-11-30
End date: 2010-12-07
Other drugs received by patient: Ecomer; Bisoprolol Fumarate
Possible Navelbine side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-23
Patient: 69 year old female, weighing 57.1 kg (125.6 pounds)
Reactions: Febrile Neutropenia, Neutropenia, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Navelbine
Possible Navelbine side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-02
Patient: 67 year old female
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Febrile Neutropenia, Mean Cell Volume Increased, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 230 mg iv
Indication: Lung Adenocarcinoma Metastatic
Start date: 2010-03-01
End date: 2010-07-15
Navelbine
Dosage: 25 mg iv
Indication: Lung Adenocarcinoma Metastatic
Start date: 2010-03-01
End date: 2010-07-25
Possible Navelbine side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Israel on 2012-02-06
Patient: 52 year old female
Reactions: Dyspnoea, Rales, Wheezing, Febrile Neutropenia, Pulmonary Oedema, Pleural Effusion, Tachypnoea, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Navelbine
Possible Navelbine side effects in 64 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-29
Patient: 64 year old female
Reactions: Confusional State, Abdominal Pain, Diarrhoea, Febrile Neutropenia, Muscle Spasms, Haematotoxicity, Infection
Drug(s) suspected as cause:
Navelbine
Dosage: 45 mg
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-12
Cisplatin
Dosage: 144 mg
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-12
Cisplatin
Dosage: 146 mg
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-12
Navelbine
Dosage: 45 mg
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-12
Cisplatin
Dosage: 146 mg
Indication: non-Small Cell Lung Cancer
Start date: 2005-08-18
Navelbine
Dosage: 46 mg, iv
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-12
Navelbine
Dosage: 45 mg, iv
Indication: non-Small Cell Lung Cancer
Start date: 2005-08-18
|